Free Trial

VistaGen Therapeutics (VTGN) SEC Filings & 10K Form

VistaGen Therapeutics logo
$2.02 -0.02 (-0.74%)
Closing price 07/3/2025 03:33 PM Eastern
Extended Trading
$2.03 +0.00 (+0.25%)
As of 07/3/2025 04:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent VistaGen Therapeutics SEC Filings

DateFilerForm TypeView
07/01/2025
4:48 PM
Singh Shawn (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
4:49 PM
Anderson Cynthia Lynn (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
4:50 PM
Adler Reid G. (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
4:51 PM
Prince Joshua S. (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
3:59 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2025
4:15 PM
Singh Shawn (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
4:15 PM
Adler Reid G. (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
4:15 PM
Prince Joshua S. (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
4:15 PM
Anderson Cynthia Lynn (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
4:15 PM
Cote Elissa S. (Reporting)
VistaGen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/25/2025
4:16 PM
Cote Elissa S. (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2025
3:43 PM
VistaGen Therapeutics (Filer)
Form 424B5
06/17/2025
3:44 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2025
3:51 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
3:40 PM
GREAT POINT PARTNERS LLC (Filed by)
VistaGen Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
12:01 PM
STEMPOINT CAPITAL LP (Filed by)
VistaGen Therapeutics (Subject)
Form SCHEDULE 13G/A
02/13/2025
4:25 PM
VistaGen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/13/2025
3:45 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
4:04 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
4:16 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
4:39 PM
Anderson Cynthia Lynn (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:40 PM
Prince Joshua S. (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:28 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
3:49 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:53 PM
Nantahala Capital Management, LLC (Filed by)
VistaGen Therapeutics (Subject)
Form SCHEDULE 13G/A
09/23/2024
7:49 AM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
4:00 PM
FitzPatrick Margaret M (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
4:00 PM
Rotunno Mary L. (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
4:00 PM
Cunningham Ann Michelle (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
4:00 PM
Curley Joanne (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
4:00 PM
GIN JERRY B (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
4:00 PM
SAXE JON S (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:49 PM
VistaGen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
3:53 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2024
6:00 PM
VistaGen Therapeutics (Filer)
Form DEF 14A
07/16/2024
6:04 PM
VistaGen Therapeutics (Filer)
Form DEFA14A
07/12/2024
3:27 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:34 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VTGN) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners